Table 3.
Sensitivity analysis of association between crude oil exposures and acute neurologic symptoms, excluding responders with pre-existing specific neurologic conditions.
| Acute neurological symptom | Exposure level | Inhalation |
Skin contact |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All active duty (N = 1638) |
Active duty - no pre-existing conditions (N = 1626) |
All active duty (N = 1117) |
Active duty - no pre-existing conditions (N = 1107) |
||||||||||||||
| Na | PR (adj.)b | (9a5% CI) | p-Trend | Na | PR (adj.)b | (95% CI) | p-Trend | N | PR (adj.)b | (95% CI) | p-Trend | N | PR (adj.)b | (95% CI) | p-Trend | ||
| Headaches | Never | 368 | 1.00 | 338 | 530 | 585 | 1.00 | ||||||||||
| Rarely | 282 | 1.30 | (1.14–1.47) | 258 | 1.22 | 1.10–1.36 | 312 | 1.28 | 1.16–1.37 | 335 | 1.37 | (1.24–1.52) | |||||
| Sometimes | 297 | 1.62 | (1.43–1.84) | 277 | 1.48 | 1.36–1.67 | 181 | 1.41 | 1.30–1.53 | 199 | 1.55 | (1.39–1.73) | |||||
| Most/all times | 244 | 1.81 | (1.59–2.08) | < 0.0001 | 219 | 1.61 | 1.44–1.80 | < 0.0001 | 69 | 1.36 | 1.22–1.57 | < 0.0001 | 72 | 1.57 | (1.38–1.78) | < 0.0001 | |
| Lightheadedness/dizziness | Never | 85 | 1.00 | 83 | 146 | 150 | 1.00 | ||||||||||
| Rarely | 84 | 1.52 | (1.12–2.04) | 82 | 1.51 | 1.19–1.90 | 105 | 1.54 | 1.28–1.86 | 111 | 1.68 | (1.32–2.12) | |||||
| Sometimes | 106 | 2.25 | (1.69–3.00) | 96 | 2.15 | 1.71–2.70 | 90 | 2.19 | 1.79–2.68 | 97 | 2.65 | (2.09–3.36) | |||||
| Most/all times | 129 | 3.60 | (2.70–4.80) | < 0.0001 | 125 | 2.78 | 2.17–3.56 | < 0.0001 | 45 | 2.59 | 2.00–3.36 | < 0.0001 | 46 | 3.46 | (2.56–4.67) | < 0.0001 | |
| Difficulty concentrating | Never | 74 | 1.00 | 73 | 127 | 128 | 1.00 | ||||||||||
| Rarely | 61 | 1.27 | (0.91–1.78) | 61 | 1.10 | 0.87–1.39 | 60 | 1.16 | 0.933–1.44 | 60 | 1.12 | (0.83–1.51) | |||||
| Sometimes | 66 | 1.66 | (1.19–2.33) | 66 | 1.23 | 0.96–1.58 | 58 | 1.65 | 1.29–2.11 | 58 | 2.05 | (1.50–2.80) | |||||
| Most/all times | 61 | 1.96 | (1.36–2.83) | 0.0001 | 61 | 1.36 | 1.36–1.83 | < 0.0001 | 16 | 1.11 | 0.69–1.77 | 0.0001 | 16 | 1.67 | (0.99–2.81) | 0.0001 | |
| Numbness/tingling sensation | Never | 29 | 1.00 | 26 | 48 | 52 | 1.00 | ||||||||||
| Rarely | 25 | 1.29 | (0.74–2.23) | 22 | 1.27 | 0.85–1.89 | 30 | 1.35 | 0.97–1.87 | 31 | 1.33 | (0.85–2.09) | |||||
| Sometimes | 35 | 2.20 | (1.30–3.71) | 35 | 1.89 | 1.27–2.82 | 33 | 2.10 | 1.46–3.02 | 35 | 2.84 | (1.80–4.49) | |||||
| Most/all times | 38 | 3.20 | (1.86–5.51) | < 0.0001 | 37 | 2.53 | 1.64–3.90 | < 0.0001 | 9 | 1.82 | 1.00–3.32 | 0.0002 | 9 | 2.19 | (1.02–4.67) | < 0.0001 | |
| Blurred/double vision | Never | 33 | 1.00 | 27 | 38 | 47 | 1.00 | ||||||||||
| Rarely | 23 | 1.13 | (0.65–1.96) | 17 | 1.28 | 0.84–1.95 | 19 | 1.17 | 0.78–1.74 | 26 | 1.39 | (0.86–2.26) | |||||
| Sometimes | 24 | 1.48 | (0.84–2.58) | 18 | 1.32 | 0.83–2.09 | 27 | 2.69 | 1.81–3.99 | 34 | 3.62 | (2.27–5.77) | |||||
| Most/all times | 38 | 3.17 | (1.86–5.42) | < 0.0001 | 33 | 2.41 | 1.51–3.86 | < 0.0001 | 11 | 2.25 | 1.16–4.34 | < 0.0001 | 11 | 3.38 | (1.70–6.75) | < 0.0001 | |
| Memory loss/confusion | Never | 18 | 1.00 | 18 | 30 | 30 | 1.00 | ||||||||||
| Rarely | 14 | 1.15 | (0.56–2.35) | 14 | 0.97 | 0.57–1.65 | 18 | 1.31 | 0.85–2.04 | 18 | 1.35 | (0.75–2.43) | |||||
| Sometimes | 25 | 2.52 | (1.32–4.81) | 25 | 1.90 | 1.15–3.11 | 22 | 2.11 | 1.28–3.49 | 22 | 3.18 | (1.75–5.76) | |||||
| Most/all times | 19 | 2.35 | (1.12–4.95) | 0.004 | 19 | 1.45 | 0.78–2.69 | 0.0037 | 6 | 1.66 | 0.69–4.00 | 0.0015 | 6 | 2.25 | (0.83–6.12) | 0.0015 | |
With the outcome and exposure.
Adjusted for: age, sex, dispersant contact, exhaust exposure, smoking, heat index and hours of sleep per night during deployment.